Literature DB >> 18824872

Functional characterization of hepatitis B virus X protein based on the inhibition of tumorigenesis in nude mice injected with CCL13-HBx cells.

Chan-Yen Kuo1, Jing-Chyi Wang, Shih-Lan Hsu, Guang-Yuh Hwang.   

Abstract

OBJECTIVE: This study aimed to determine the effects of HBx on the inhibition of tumorigenesis in nude mice injected with CCL13-HBx cells. Therefore, the characteristics of the induced tumors and the phenomenon of apoptosis were assessed.
METHODS: The induced tumors were identified using the specific marker of hepatocellular carcinoma (HCC), anti-alpha-fetoprotein (AFP), and their characteristics were pathologically examined. Apoptosis was detected by DNA fragmentation, and the expression of the proapoptotic proteins p53, Bax, Bad, caspase-3, and caspase-8 and the anti-apoptotic protein Bcl-2 was detected by Western blotting. To identify possible molecules involved in the inhibition of tumorigenesis, extracts of the induced tumors were separated by 2D-PAGE, and the proteins were identified by MS.
RESULTS: The tumors of the nude mice injected with CCL13 and CCL13-HBx cells were identified as HCCs. Moreover, HBx was found to suppress tumor growth via apoptosis in the nude mice injected with CCL13-HBx cells. The MS findings revealed that phosphorylated myosin light chain was a candidate molecule involved in the inhibition of tumorigenesis.
CONCLUSION: HBx suppressed tumorigenesis in the nude mice injected with CCL13-HBx cells, which proved to be a good animal model for the in vivo study of the effects of HBx on tumorigenesis. Copyright 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18824872     DOI: 10.1159/000158522

Source DB:  PubMed          Journal:  Intervirology        ISSN: 0300-5526            Impact factor:   1.763


  1 in total

1.  The Increased Level of Serum p53 in Hepatitis B-Associated Liver Cirrhosis.

Authors:  Parisa Shahnazari; Kourosh Sayehmiri; Zarrin Minuchehr; Ardavan Parhizkar; Hossein Poustchi; Ghodratollah Montazeri; Ashraf Mohamadkhani
Journal:  Iran J Med Sci       Date:  2014-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.